AKRX : NASDAQ : Health Technology
$18.73 -0.05 | -0.27%
Today's Range: 18.41 - 18.82
Avg. Daily Volume: 2094400.0
03/19/18 - 3:59 PM ET

Financial Analysis

AKORN INC's gross profit margin for the fourth quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. Sales and net income fell significantly; although net income growth outperformed the average competitor in its industry, revenue growth did not. AKORN INC is extremely liquid. Currently, the Quick Ratio is 2.98 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.

At the same time, stockholders' equity ("net worth") has remained virtually unchanged only increasing by 1.47% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.

Income Statement Q4 FY17 Q4 FY16
Net Sales ($mil)186.06283.67
EBITDA ($mil)8.11121.24
EBIT ($mil)-13.2799.28
Net Income ($mil)-65.2232.46

Balance Sheet Q4 FY17 Q4 FY16
Cash & Equiv. ($mil)368.12201.88
Total Assets ($mil)1909.511973.72
Total Debt ($mil)815.2809.98
Equity ($mil)831.25819.18

Profitability Q4 FY17 Q4 FY16
Gross Profit Margin48.061.67
EBITDA Margin4.3642.74
Operating Margin-7.1335.0
Sales Turnover0.440.57
Return on Assets-1.289.33
Return on Equity-2.9522.49
Debt Q4 FY17 Q4 FY16
Current Ratio4.273.91
Interest Expense10.8411.41
Interest Coverage-1.228.7

Share Data Q4 FY17 Q4 FY16
Shares outstanding (mil)125.09124.39
Div / share0.00.0
Book value / share6.656.59
Institutional Own % n/a n/a
Avg Daily Volume2131643.02189435.0


HOLD. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. To use another comparison, its price-to-book ratio of 2.82 indicates a discount versus the S&P 500 average of 3.28 and a significant discount versus the industry average of 7.60. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, AKORN INC proves to trade at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
AKRX NM Peers 105.10   AKRX 9.42 Peers 17.82

Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.

AKRX's P/E is negative making this valuation measure meaningless.


Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

AKRX is trading at a significant discount to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
AKRX 27.60 Peers 14.20   AKRX NA Peers 0.51

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

AKRX is trading at a significant premium to its peers.


Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
AKRX 2.82 Peers 7.60   AKRX -112.83 Peers -278.29

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

AKRX is trading at a significant discount to its peers.


Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

AKRX is expected to have an earnings growth rate that significantly exceeds its peers.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
AKRX 2.79 Peers 25.39   AKRX -24.70 Peers 23.77

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

AKRX is trading at a significant discount to its industry on this measurement.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

AKRX significantly trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades